🇺🇸 FDA
Patent

US 9512191

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

granted A61KA61K38/00A61K38/08

Quick answer

US patent 9512191 (Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory) held by The Regents of the University of California expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/1709